339 related articles for article (PubMed ID: 38371298)
1. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.
Cheng J; Zhou L; Wang H
Front Cell Infect Microbiol; 2024; 14():1296295. PubMed ID: 38371298
[TBL] [Abstract][Full Text] [Related]
2. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.
Lu H; Gao NL; Tong F; Wang J; Li H; Zhang R; Ma H; Yang N; Zhang Y; Wang Y; Liang Z; Zeng H; Chen WH; Dong X
Microbiol Spectr; 2021 Dec; 9(3):e0080221. PubMed ID: 34787462
[TBL] [Abstract][Full Text] [Related]
4. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between the lung microbiome and lung cancer.
Meng Y; Mao Y; Tang Z; Qiu X; Bajinka O; Tan Y; Song Z
Microb Pathog; 2023 May; 178():106062. PubMed ID: 36914054
[TBL] [Abstract][Full Text] [Related]
6. The Role of Oral Microbiota in Chronic Obstructive Pulmonary Disease.
Wen S; Zhang Z; Ouyang Y; Liu J; Liang Z; Pi Y; Su Z; Chen D; Guo L; Jiang Q; Yang L; Wang Y
Respiration; 2022; 101(9):859-868. PubMed ID: 35790142
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial.
Bingula R; Filaire E; Molnar I; Delmas E; Berthon JY; Vasson MP; Bernalier-Donadille A; Filaire M
Respir Res; 2020 May; 21(1):129. PubMed ID: 32450847
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis of lower respiratory tract microbiome are associated with proinflammatory states in non-small cell lung cancer patients.
Li Y; Rao G; Zhu G; Cheng C; Yuan L; Li C; Gao J; Tang J; Wang Z; Li W
Thorac Cancer; 2024 Jan; 15(2):111-121. PubMed ID: 38041547
[TBL] [Abstract][Full Text] [Related]
9. Interplay between the lung microbiome and lung cancer.
Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
[TBL] [Abstract][Full Text] [Related]
10. Gut-lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data.
De Nuccio F; Piscitelli P; Toraldo DM
Lung; 2022 Dec; 200(6):773-781. PubMed ID: 36241745
[TBL] [Abstract][Full Text] [Related]
11. The association between the respiratory tract microbiome and clinical outcomes in patients with COPD.
Yu S; Zhang H; Wan L; Xue M; Zhang Y; Gao X
Microbiol Res; 2023 Jan; 266():127244. PubMed ID: 36335803
[TBL] [Abstract][Full Text] [Related]
12. Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis.
Zhang Y; Chen X; Wang Y; Li L; Ju Q; Zhang Y; Xi H; Wang F; Qiu D; Liu X; Chang N; Zhang W; Zhang C; Wang K; Li L; Zhang J
Front Cell Infect Microbiol; 2023; 13():1261284. PubMed ID: 37915846
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Lung and Oral Microbiomes in Lung Cancer Patients Using Culturomics and 16S rRNA Gene Sequencing.
Sun Y; Liu Y; Li J; Tan Y; An T; Zhuo M; Pan Z; Ma M; Jia B; Zhang H; Wang Z; Yang R; Bi Y
Microbiol Spectr; 2023 Jun; 11(3):e0031423. PubMed ID: 37092999
[TBL] [Abstract][Full Text] [Related]
14. The role of oral microbiome in respiratory health and diseases.
Pathak JL; Yan Y; Zhang Q; Wang L; Ge L
Respir Med; 2021; 185():106475. PubMed ID: 34049183
[TBL] [Abstract][Full Text] [Related]
15. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
16. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
[TBL] [Abstract][Full Text] [Related]
17. The microbiome and gynaecological cancer development, prevention and therapy.
Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM
Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434
[TBL] [Abstract][Full Text] [Related]
18. Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.
Mendez R; Banerjee S; Bhattacharya SK; Banerjee S
IUBMB Life; 2019 Feb; 71(2):152-165. PubMed ID: 30466159
[TBL] [Abstract][Full Text] [Related]
19. Respiratory Tract Oncobiome in Lung Carcinogenesis: Where Are We Now?
Czarnecka-Chrebelska KH; Kordiak J; Brzeziańska-Lasota E; Pastuszak-Lewandoska D
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894302
[TBL] [Abstract][Full Text] [Related]
20. Lung microbiome alterations in NSCLC patients.
Zheng L; Sun R; Zhu Y; Li Z; She X; Jian X; Yu F; Deng X; Sai B; Wang L; Zhou W; Wu M; Li G; Tang J; Jia W; Xiang J
Sci Rep; 2021 Jun; 11(1):11736. PubMed ID: 34083661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
